Neoadjuvant Chemotherapy (NC) Should Be Administered to Fit Patients With Newly Diagnosed, Potentially Resectable Muscle-Invasive Urothelial Cancer (MIUC) of the Bladder – A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral Process
Canadian Urological Association Journal - Canada
doi 10.5489/cuaj.1506
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 9, 2013
Authors
Publisher
Canadian Urological Association Journal